CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
8.96
0.08 (0.90%)
At close: Oct 03, 2025, 3:59 PM
8.88
-0.84%
After-hours: Oct 03, 2025, 07:20 PM EDT
0.90% (1D)
| Bid | 8.71 |
| Market Cap | 5.15M |
| Revenue (ttm) | 3.14K |
| Net Income (ttm) | -15.46M |
| EPS (ttm) | 2083.96 |
| PE Ratio (ttm) | n/a |
| Forward PE | -1.32 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9 |
| Volume | 7,883 |
| Avg. Volume (20D) | 50,625 |
| Open | 8.87 |
| Previous Close | 8.88 |
| Day's Range | 8.68 - 8.96 |
| 52-Week Range | 4.93 - 222.00 |
| Beta | 0.74 |
| Ex-Dividend Date | n/a |
About CNSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-15.59%
CNS Pharmaceuticals shares are trading lower. The ...
Unlock content with
Pro Subscription
2 months ago
-10.7%
CNS Pharmaceuticals shares are trading lower after the company announced a 1-for-12 reverse split.
2 months ago · accessnewswire.com
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect SegmentHOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri...